165 related articles for article (PubMed ID: 19840789)
1. Chronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic pain.
Yalcin I; Tessier LH; Petit-Demoulière N; Waltisperger E; Hein L; Freund-Mercier MJ; Barrot M
Exp Neurol; 2010 Jan; 221(1):115-21. PubMed ID: 19840789
[TBL] [Abstract][Full Text] [Related]
2. beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain.
Yalcin I; Choucair-Jaafar N; Benbouzid M; Tessier LH; Muller A; Hein L; Freund-Mercier MJ; Barrot M
Ann Neurol; 2009 Feb; 65(2):218-25. PubMed ID: 19259968
[TBL] [Abstract][Full Text] [Related]
3. Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.
Yalcin I; Tessier LH; Petit-Demoulière N; Doridot S; Hein L; Freund-Mercier MJ; Barrot M
Neurobiol Dis; 2009 Mar; 33(3):386-94. PubMed ID: 19084064
[TBL] [Abstract][Full Text] [Related]
4. Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment.
Choucair-Jaafar N; Yalcin I; Rodeau JL; Waltisperger E; Freund-Mercier MJ; Barrot M
Br J Pharmacol; 2009 Dec; 158(7):1683-94. PubMed ID: 19912227
[TBL] [Abstract][Full Text] [Related]
5. The antiallodynic action of nortriptyline and terbutaline is mediated by β(2) adrenoceptors and δ opioid receptors in the ob/ob model of diabetic polyneuropathy.
Choucair-Jaafar N; Salvat E; Freund-Mercier MJ; Barrot M
Brain Res; 2014 Feb; 1546():18-26. PubMed ID: 24361988
[TBL] [Abstract][Full Text] [Related]
6. From antidepressant drugs to beta-mimetics: preclinical insights on potential new treatments for neuropathic pain.
Barrot M; Yalcin I; Choucair-Jaafar N; Benbouzid M; Freund-Mercier MJ
Recent Pat CNS Drug Discov; 2009 Nov; 4(3):182-9. PubMed ID: 19538157
[TBL] [Abstract][Full Text] [Related]
7. Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice.
Benbouzid M; Choucair-Jaafar N; Yalcin I; Waltisperger E; Muller A; Freund-Mercier MJ; Barrot M
Eur J Pain; 2008 Nov; 12(8):1008-17. PubMed ID: 18331804
[TBL] [Abstract][Full Text] [Related]
8. Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia.
Benbouzid M; Gavériaux-Ruff C; Yalcin I; Waltisperger E; Tessier LH; Muller A; Kieffer BL; Freund-Mercier MJ; Barrot M
Biol Psychiatry; 2008 Mar; 63(6):633-6. PubMed ID: 17693391
[TBL] [Abstract][Full Text] [Related]
9. Antidepressants suppress neuropathic pain by a peripheral β2-adrenoceptor mediated anti-TNFα mechanism.
Bohren Y; Tessier LH; Megat S; Petitjean H; Hugel S; Daniel D; Kremer M; Fournel S; Hein L; Schlichter R; Freund-Mercier MJ; Yalcin I; Barrot M
Neurobiol Dis; 2013 Dec; 60():39-50. PubMed ID: 23978467
[TBL] [Abstract][Full Text] [Related]
10. Murine ventricular L-type Ca(2+) current is enhanced by zinterol via beta(1)-adrenoceptors, and is reduced in TG4 mice overexpressing the human beta(2)-adrenoceptor.
Heubach JF; Graf EM; Molenaar P; Jäger A; Schröder F; Herzig S; Harding SE; Ravens U
Br J Pharmacol; 2001 May; 133(1):73-82. PubMed ID: 11325796
[TBL] [Abstract][Full Text] [Related]
11. Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved.
Zhao X; Xu Y; Zhao Q; Chen CR; Liu AM; Huang ZL
Neuropharmacology; 2012 Feb; 62(2):843-54. PubMed ID: 21945716
[TBL] [Abstract][Full Text] [Related]
12. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala.
Narita M; Kaneko C; Miyoshi K; Nagumo Y; Kuzumaki N; Nakajima M; Nanjo K; Matsuzawa K; Yamazaki M; Suzuki T
Neuropsychopharmacology; 2006 Apr; 31(4):739-50. PubMed ID: 16123756
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of chronic treatment with a β2-adrenoceptor agonist relieving neuropathic pain in mice.
Choucair-Jaafar N; Beetz N; Gilsbach R; Yalcin I; Waltisperger E; Freund-Mercier MJ; Monassier L; Hein L; Barrot M
Neuropharmacology; 2011; 61(1-2):51-60. PubMed ID: 21352833
[TBL] [Abstract][Full Text] [Related]
14. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation.
Miura S; Kawanaka K; Kai Y; Tamura M; Goto M; Shiuchi T; Minokoshi Y; Ezaki O
Endocrinology; 2007 Jul; 148(7):3441-8. PubMed ID: 17446185
[TBL] [Abstract][Full Text] [Related]
15. Exogenous melatonin abolishes mechanical allodynia but not thermal hyperalgesia in neuropathic pain. The role of the opioid system and benzodiazepine-gabaergic mechanism.
Zurowski D; Nowak L; Machowska A; Wordliczek J; Thor PJ
J Physiol Pharmacol; 2012 Dec; 63(6):641-7. PubMed ID: 23388480
[TBL] [Abstract][Full Text] [Related]
16. Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia.
Bohren Y; Karavelic D; Tessier LH; Yalcin I; Gavériaux-Ruff C; Kieffer BL; Freund-Mercier MJ; Barrot M
Eur J Pain; 2010 Aug; 14(7):700-704. PubMed ID: 20056557
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of the antidepressant-like effects of clenbuterol by central administration of beta-adrenergic antagonists in rats.
Zhang HT; Huang Y; O'Donnell JM
Psychopharmacology (Berl); 2003 Oct; 170(1):102-7. PubMed ID: 12898120
[TBL] [Abstract][Full Text] [Related]
18. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
19. Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain.
Obara I; Parkitna JR; Korostynski M; Makuch W; Kaminska D; Przewlocka B; Przewlocki R
Pain; 2009 Feb; 141(3):283-291. PubMed ID: 19147290
[TBL] [Abstract][Full Text] [Related]
20. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
